Juliet Moritz


Patient Engagement and Advocacy: Advancing the Cause of Clinical Drug Research

January 06, 2020

For years, Duchenne muscular dystrophy drug trials included a specific endpoint requiring that they enroll only patients who were still able to walk. That changed when a DMD-focused advocacy organization took the matter up with the FDA and helped develop new trial guidelines.

Drug Developers Embrace the Rising Prominence - and Influence - of Patient Advocacy

February 24, 2017

Patient advocates are witnessing a shift in the culture of drug development as sponsors and regulatory agencies show more interest in incorporating patient perspectives.